We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$21.5B
AUM Growth
-$2.05B
Cap. Flow
+$21.4B
Cap. Flow %
99.3%
Top 10 Hldgs %
12.62%
Holding
2,011
New
1,880
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$587M
2
AAPL icon
Apple
AAPL
+$541M
3
TSM icon
TSMC
TSM
+$392M
4
CSX icon
CSX Corp
CSX
+$262M
5
AMZN icon
Amazon
AMZN
+$237M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 21.91%
2 Healthcare 13.72%
3 Consumer Discretionary 12.54%
4 Financials 11.02%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
1826
Ardelyx
ARDX
$1.25B
$16K ﹤0.01%
+13,531
New +$12.9K
RTB
1827
RTB Digital
RTB
$207M
$16K ﹤0.01%
+47
New +$16.9K
HGEN
1828
DELISTED
HUMANIGEN, INC.
HGEN
$16K ﹤0.01%
+87,586
New +$47.1K
CTXR icon
1829
Citius Pharmaceuticals
CTXR
$14.5M
$15K ﹤0.01%
+500
New +$13.7K
SPPI
1830
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$15K ﹤0.01%
+34,208
New +$33.6K
CLVS
1831
DELISTED
Clovis Oncology, Inc.
CLVS
$15K ﹤0.01%
+12,535
New +$19.5K
AKBA icon
1832
Akebia Therapeutics
AKBA
$327M
$14K ﹤0.01%
+43,873
New +$17.2K
CRIS icon
1833
Curis
CRIS
$9.71M
$14K ﹤0.01%
+49
New +$19.8K
HOOK
1834
DELISTED
HOOKIPA Pharma
HOOK
$14K ﹤0.01%
+1,012
New +$15.5K
TNXP icon
1835
Tonix Pharmaceuticals
TNXP
$162M
$14K ﹤0.01%
+1
New +$24.5K
FFAI
1836
Faraday Future Intelligent Electric
FFAI
$16.9M
0
MMAT
1837
DELISTED
Meta Materials Inc. Common Stock
MMAT
$14K ﹤0.01%
+220
New +$19.3K
LTRPA
1838
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$14K ﹤0.01%
+12,500
New +$13.2K
BTWNW
1839
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$14K ﹤0.01%
+106,672
New +$21.4K
SURF
1840
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$14K ﹤0.01%
+13,400
New +$21.4K
RUBY
1841
DELISTED
Rubius Therapeutics, Inc
RUBY
$14K ﹤0.01%
+31,143
New +$23.3K
VHC icon
1842
VirnetX Holding Corp
VHC
$52.6M
$13K ﹤0.01%
+546
New +$17.6K
SEEL
1843
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$13K ﹤0.01%
+3
New +$11.8K
AFIB
1844
DELISTED
Acutus Medical Inc
AFIB
$13K ﹤0.01%
+15,158
New +$18.3K
INFI
1845
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$13K ﹤0.01%
+11,025
New +$11.9K
IDEX
1846
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$13K ﹤0.01%
+379
New +$28.7K
NMTR
1847
DELISTED
9 Meters Biopharma
NMTR
$13K ﹤0.01%
+2,959
New +$14.7K
QTNT
1848
DELISTED
Quotient Limited Ordinary Shares
QTNT
$13K ﹤0.01%
+2,198
New +$19.8K
ELTX icon
1849
Elicio Therapeutics
ELTX
$80.4M
$12K ﹤0.01%
+1,261
New +$13.2K
FBRX icon
1850
Forte Biosciences
FBRX
$1.16B
$12K ﹤0.01%
+430
New +$13.7K

Similar funds

Man Group's Q3 2022 Portfolio in Review

As of Q3 2022, Man Group held 2,011 positions worth $21.5B, down 8.7% from $23.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group deployed $21.4B of net new capital in Q3 2022, opening 1,880 new positions. Its largest new stake was Microsoft: 2,221,283 shares worth $517M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Man Group's largest Q3 2022 buy was Microsoft: 2,221,283 shares worth $517M.
  • Man Group's ten largest holdings make up 13% of its $21.5B portfolio in Q3 2022.
  • Man Group opened 1,880 new positions and closed 0 in Q3 2022.
  • Man Group's portfolio value fell 8.7% quarter-over-quarter to $21.5B.

Based on Man Group's 13F filing for Q3 2022, filed 14 Nov 2022.